Biomarker Clinical Phase Outsourcing Services Global Market Report 2024

Biomarker Clinical Phase Outsourcing Services Global Market Report 2024

Including: 1) By Type: Surrogate Endpoints; Predictive Biomarker; Prognostic Biomarker; Safety Biomarker2) By Service Type: Biomarker Validation; Biomarker Testing Services; Biomarker Sample Analysis3) By Therapeutic Area: Oncology; Neurology; Cardiology; Autoimmune Diseases4) By End-User: Pharmaceutical Companies; Biotechnology Companies; Academic And Research InstitutionsCovering: Thermo Fisher Scientific Inc.; Labcorp Drug Development Inc.; ICON plc; Eurofins Scientific SE; WuXi AppTec Co. Ltd.


Biomarker Clinical Phase Outsourcing Services Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biomarker clinical phase outsourcing services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for biomarker clinical phase outsourcing services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biomarker clinical phase outsourcing services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Type: Surrogate Endpoints; Predictive Biomarker; Prognostic Biomarker; Safety Biomarker; Other Biomarker Types

2) By Service Type: Biomarker Validation; Biomarker Testing Services; Biomarker Sample Analysis

3) By Therapeutic Area: Oncology; Neurology; Cardiology; Autoimmune Diseases; Other Therapeutic Areas

4) By End-User: Pharmaceutical Companies; Biotechnology Companies; Academic And Research Institutions

Companies Mentioned: Thermo Fisher Scientific Inc.; LabCorp Drug Development Inc.; ICON plc; Eurofins Scientific SE; WuXi AppTec Co. Ltd.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Biomarker Clinical Phase Outsourcing Services Market Characteristics
3. Biomarker Clinical Phase Outsourcing Services Market Trends And Strategies
4. Biomarker Clinical Phase Outsourcing Services Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Biomarker Clinical Phase Outsourcing Services Market Size and Growth
5.1. Global Biomarker Clinical Phase Outsourcing Services Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Biomarker Clinical Phase Outsourcing Services Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Biomarker Clinical Phase Outsourcing Services Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Biomarker Clinical Phase Outsourcing Services Market Segmentation
6.1. Global Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Surrogate Endpoints
Predictive Biomarker
Prognostic Biomarker
Safety Biomarker
Other Biomarker Types
6.2. Global Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Biomarker Validation
Biomarker Testing Services
Biomarker Sample Analysis
6.3. Global Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oncology
Neurology
Cardiology
Autoimmune Diseases
Other Therapeutic Areas
6.4. Global Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pharmaceutical Companies
Biotechnology Companies
Academic And Research Institutions
7. Biomarker Clinical Phase Outsourcing Services Market Regional And Country Analysis
7.1. Global Biomarker Clinical Phase Outsourcing Services Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Biomarker Clinical Phase Outsourcing Services Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Biomarker Clinical Phase Outsourcing Services Market
8.1. Asia-Pacific Biomarker Clinical Phase Outsourcing Services Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Biomarker Clinical Phase Outsourcing Services Market
9.1. China Biomarker Clinical Phase Outsourcing Services Market Overview
9.2. China Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Biomarker Clinical Phase Outsourcing Services Market
10.1. India Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Biomarker Clinical Phase Outsourcing Services Market
11.1. Japan Biomarker Clinical Phase Outsourcing Services Market Overview
11.2. Japan Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Biomarker Clinical Phase Outsourcing Services Market
12.1. Australia Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Biomarker Clinical Phase Outsourcing Services Market
13.1. Indonesia Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Biomarker Clinical Phase Outsourcing Services Market
14.1. South Korea Biomarker Clinical Phase Outsourcing Services Market Overview
14.2. South Korea Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Biomarker Clinical Phase Outsourcing Services Market
15.1. Western Europe Biomarker Clinical Phase Outsourcing Services Market Overview
15.2. Western Europe Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Biomarker Clinical Phase Outsourcing Services Market
16.1. UK Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Biomarker Clinical Phase Outsourcing Services Market
17.1. Germany Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Biomarker Clinical Phase Outsourcing Services Market
18.1. France Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Biomarker Clinical Phase Outsourcing Services Market
19.1. Italy Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Biomarker Clinical Phase Outsourcing Services Market
20.1. Spain Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Biomarker Clinical Phase Outsourcing Services Market
21.1. Eastern Europe Biomarker Clinical Phase Outsourcing Services Market Overview
21.2. Eastern Europe Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Biomarker Clinical Phase Outsourcing Services Market
22.1. Russia Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Biomarker Clinical Phase Outsourcing Services Market
23.1. North America Biomarker Clinical Phase Outsourcing Services Market Overview
23.2. North America Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Biomarker Clinical Phase Outsourcing Services Market
24.1. USA Biomarker Clinical Phase Outsourcing Services Market Overview
24.2. USA Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Biomarker Clinical Phase Outsourcing Services Market
25.1. Canada Biomarker Clinical Phase Outsourcing Services Market Overview
25.2. Canada Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Biomarker Clinical Phase Outsourcing Services Market
26.1. South America Biomarker Clinical Phase Outsourcing Services Market Overview
26.2. South America Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Biomarker Clinical Phase Outsourcing Services Market
27.1. Brazil Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Biomarker Clinical Phase Outsourcing Services Market
28.1. Middle East Biomarker Clinical Phase Outsourcing Services Market Overview
28.2. Middle East Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Biomarker Clinical Phase Outsourcing Services Market
29.1. Africa Biomarker Clinical Phase Outsourcing Services Market Overview
29.2. Africa Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Biomarker Clinical Phase Outsourcing Services Market Competitive Landscape And Company Profiles
30.1. Biomarker Clinical Phase Outsourcing Services Market Competitive Landscape
30.2. Biomarker Clinical Phase Outsourcing Services Market Company Profiles
30.2.1. Thermo Fisher Scientific Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Labcorp Drug Development Inc.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. ICON plc
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Eurofins Scientific SE
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. WuXi AppTec Co. Ltd.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Biomarker Clinical Phase Outsourcing Services Market Other Major And Innovative Companies
31.1. Syneos Health Inc.
31.2. Intertek Group plc
31.3. Charles River Laboratories International Inc.
31.4. Parexel International Corporation
31.5. QIAGEN N.V.
31.6. Medpace Inc.
31.7. Bioclinica Inc.
31.8. Evotec SE
31.9. GenScript Biotech Corporation
31.10. Precision for Medicine Inc.
31.11. BioAgilytix Labs LLC
31.12. Celerion Inc.
31.13. Frontage Laboratories Inc.
31.14. SomaLogic Inc.
31.15. Selvita S.A.
32. Global Biomarker Clinical Phase Outsourcing Services Market Competitive Benchmarking
33. Global Biomarker Clinical Phase Outsourcing Services Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Biomarker Clinical Phase Outsourcing Services Market
35. Biomarker Clinical Phase Outsourcing Services Market Future Outlook and Potential Analysis
35.1 Biomarker Clinical Phase Outsourcing Services Market In 2028 - Countries Offering Most New Opportunities
35.2 Biomarker Clinical Phase Outsourcing Services Market In 2028 - Segments Offering Most New Opportunities
35.3 Biomarker Clinical Phase Outsourcing Services Market In 2028 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings